Literature DB >> 11263984

In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP.

W Deng1, M Obrocka, I Fischer, D J Prockop.   

Abstract

Human marrow stromal cells (hMSCs) are multipotential stem cells that can be differentiated into bone, cartilage, fat, and muscle. In the experiments here, we found that undifferentiated cultures of hMSCs express some markers characteristic of neural cells such as microtubule-associated protein 1B (MAP1B), neuron-specific tubulin (TuJ-1), neuron-specific enolase (NSE), and vimentin. By treating hMSCs with 0.5 mM isobutylmethylxanthine (IBMX)/1 mM dibutyryl cyclic AMP (dbcAMP) for 6 days, about 25% of the hMSCs differentiated into cells with a typical neural cell morphology and with increased levels of both NSE and vimentin. The data suggested that the hMSCs may have been differentiated into early progenitors of neural cells in vitro under conditions that increase the intracellular level of cAMP. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263984     DOI: 10.1006/bbrc.2001.4570

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  99 in total

1.  Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery.

Authors:  C P Hofstetter; E J Schwarz; D Hess; J Widenfalk; A El Manira; Darwin J Prockop; L Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 2.  Genetic engineering of mesenchymal stem cells and its application in human disease therapy.

Authors:  Conrad P Hodgkinson; José A Gomez; Maria Mirotsou; Victor J Dzau
Journal:  Hum Gene Ther       Date:  2010-10-22       Impact factor: 5.695

3.  cAMP initiates early phase neuron-like morphology changes and late phase neural differentiation in mesenchymal stem cells.

Authors:  Linxia Zhang; Linsey C Seitz; Amy M Abramczyk; Li Liu; Christina Chan
Journal:  Cell Mol Life Sci       Date:  2010-08-20       Impact factor: 9.261

Review 4.  Cell therapy in demyelinating diseases.

Authors:  Claire Rice; Christopher Halfpenny; Neil Scolding
Journal:  NeuroRx       Date:  2004-10

5.  Adult human bone marrow stromal spheres express neuronal traits in vitro and in a rat model of Parkinson's disease.

Authors:  Sokreine Suon; Ming Yang; Lorraine Iacovitti
Journal:  Brain Res       Date:  2006-07-10       Impact factor: 3.252

6.  Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination.

Authors:  Gerburg Keilhoff; Felix Stang; Alexander Goihl; Gerald Wolf; Hisham Fansa
Journal:  Cell Mol Neurobiol       Date:  2006-06-16       Impact factor: 5.046

7.  Possibility of selection of chondrogenic progenitor cells by telomere length in FGF-2-expanded mesenchymal stromal cells.

Authors:  S Yanada; M Ochi; K Kojima; P Sharman; Y Yasunaga; E Hiyama
Journal:  Cell Prolif       Date:  2006-12       Impact factor: 6.831

Review 8.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

9.  Induction of neuron-specific enolase promoter and neuronal markers in differentiated mouse bone marrow stromal cells.

Authors:  Yossef S Levy; Doron Merims; Hanna Panet; Yael Barhum; Eldad Melamed; Daniel Offen
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 10.  Bone marrow stromal cells as a therapeutic treatment for ischemic stroke.

Authors:  Zizhen Yang; Lei Zhu; Fangqin Li; Jing Wang; Huan Wan; Yujun Pan
Journal:  Neurosci Bull       Date:  2014-05-10       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.